Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections

被引:28
|
作者
Gesser, RM [1 ]
McCarroll, KA [1 ]
Woods, GL [1 ]
机构
[1] Merck Res Labs, W Point, PA USA
关键词
outpatient antimicrobial therapy; ertapenem; complicated skin infections;
D O I
10.1016/j.jinf.2003.10.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives. The patient characteristics and the efficacy and safety of ertapenem 1 g once daily vs. piperacillin-tazobactam 13.5 g divided Q6H were examined in patients who received outpatient parenteral antimicrobial therapy (OPAT) during a clinical trial of complicated skin/skin structure infections. Methods. The population analyzed included 363 patients treated at US sites in a large randomized double-blind study. Results. In this analysis, 146 (40%) patients at 19 (66%) sites were managed by OPAT. A lower proportion of treated patients who received OPAT had severe infection (12% vs. 20%, P = 0.03). In evaluable patients managed by OPAT, 45 (83.3%) of 54 treated with ertapenem and 41 (82.0%) of 50 treated with piperacillin-tazobactam were cured at the test of cure assessment 10-21 days post-therapy (OR 1.2 (95% CI, 0.4-3.2), P = 0.78). The safety profile of both drugs was generally similar; diarrhoea was the most common adverse event in both groups. Conclusions. In this trial of complicated skin/skin structure infection, OPAT was commonly used by US investigators. Among patients who received OPAT, ertapenem 1 g daily was as effective as piperacillin-tazobactam 3.375 g Q6H. (C) 2003 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 50 条
  • [31] The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials
    Deresinski, Stanley C.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 61 (01) : 103 - 109
  • [32] Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections
    Pelak, BA
    Bartizal, K
    Woods, GL
    Gesser, RM
    Motyl, M
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (02) : 129 - 133
  • [33] Activity of ertapenem (ETP) vs. piperacillin/tazobactam (P/T) in polymicrobial complicated skin and skin structure infections (CSSSI)
    Graham, D
    Holtom, P
    Lucasti, C
    Malafaia, O
    Nichols, R
    Quintero-Perez, N
    Gesser, R
    McAdams, A
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1107 - 1107
  • [34] CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
    Wilcox, Mark H.
    Corey, G. Ralph
    Talbot, George H.
    Thye, Dirk
    Friedland, David
    Baculik, Tanya
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 : iv53 - iv65
  • [35] CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
    Corey, G. Ralph
    Wilcox, Mark H.
    Talbot, George H.
    Thye, Dirk
    Friedland, David
    Baculik, Tanya
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 : iv41 - iv51
  • [36] Daptomycin versus vancomycin for complicated skin and skin structure infections: Clinical and economic outcomes
    Davis, Susan L.
    McKinnon, Peggy S.
    Hall, Levi M.
    Delgado, George, Jr.
    Rose, Warren
    Wilson, Robert E.
    Rybak, MichaelJ.
    PHARMACOTHERAPY, 2007, 27 (12): : 1611 - 1618
  • [37] Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections
    Bassetti, Matteo
    Pecori, Davide
    Cojutti, Piergiorgio
    Righi, Elda
    Pea, Federico
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (11) : 1193 - 1200
  • [38] COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) FOR INPATIENT AND OUTPATIENT TREATMENT SETTINGS
    Stephens, J. M.
    Treur, M. J.
    Heeg, B. M. S.
    Haider, S.
    Nathwani, D.
    Tice, A.
    VALUE IN HEALTH, 2008, 11 (06) : A441 - A441
  • [39] Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections
    Wilcox, MH
    JOURNAL OF CHEMOTHERAPY, 2005, 17 : 23 - 29
  • [40] Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections
    Pan, Angelo
    Cauda, Roberto
    Concia, Ercole
    Esposito, Silvano
    Sganga, Gabriele
    Stefani, Stefania
    Nicastri, Emanuele
    Lauria, Francesco N.
    Carosi, Giampiero
    Moroni, Mauro
    Ippolito, Giuseppe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S39 - S53